Fig. 1e, for lymphocytes stimulated with HBc plus CCL19 peptide or protein produced ~ 1.5-fold more (median) PBMCs migrating in response to CCL19 compared with HBc stimulation alone in hepatitis B patients (HBV +). Here, CCL19 is linked to hepatitis B virus infection.